Vontobel Holding
HOWL icon

Vontobel Holding’s Werewolf Therapeutics HOWL Stock Holding History

Vontobel Holding’s Portfolio HOWL Stock Details HOWL Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		– Sell
-60,003
Closed -$38K – 1333
2025
Q4 		$38K Buy
60,003
+24,003
+67% +$29.2K ﹤0.01% 1415
2025
Q3 		$70.9K Sell
36,000
-4,000
-10% -$5.48K ﹤0.01% 1307
2025
Q2 		$43.6K Buy
40,000
+5,000
+14% +$5.15K ﹤0.01% 1237
2025
Q1 		$34K Buy
+35,000
New +$45.8K ﹤0.01% 1075

Other funds holding HOWL

RCM
RA Capital Management Boston, Massachusetts $9.44B AUM 157.3% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
MB
MPM BioImpact Boston, Massachusetts $1.29B AUM 141.72% 1-Year Est. Return
LCM
Lynx1 Capital Management San Juan, Puerto Rico $633M AUM 173.22% 1-Year Est. Return
SFM
Sphera Funds Management Tel Aviv, Israel $630M AUM 108.65% 1-Year Est. Return
DF
DC Funds Mclean, Virginia $1.49M AUM 18.57% 1-Year Est. Return
SCM
Squadron Capital Management Westmont, Illinois $273M AUM
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Vontobel Holding's HOWL Position: Q1 2026 in Review

Vontobel Holding sold out of Werewolf Therapeutics (HOWL) in Q1 2026, closing a stake of 60,003 shares — an estimated $38K sold.

Vontobel Holding first reported a position in HOWL in Q1 2025 and held it in 4 quarters. The position peaked at $70.9K in Q3 2025. 48 funds tracked by Wall St. Rank hold HOWL as of Q1 2026.

  • Vontobel Holding reported no remaining Werewolf Therapeutics position as of Q1 2026 after selling out during the quarter.
  • Vontobel Holding sold 60,003 Werewolf Therapeutics shares in Q1 2026, an estimated $38K.
  • Vontobel Holding first reported a position in Werewolf Therapeutics in Q1 2025 and held it in 4 quarters.
  • Vontobel Holding's Werewolf Therapeutics position peaked at $70.9K in Q3 2025.
  • 48 funds tracked by Wall St. Rank held Werewolf Therapeutics as of Q1 2026.

Based on Vontobel Holding's 13F filing for Q1 2026, filed 8 May 2026.